Image

Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)

Study on new dosing of MK-6024 for liver disease patients.

Recruiting
18-80 years
All
Phase 2

This study looks at a medicine called efinopegdutide to see how it affects fat in the liver. The liver is an important organ that helps clean your blood and break down food. Efinopegdutide will be given either every two weeks or weekly for 28 weeks to see which way works better to reduce liver fat. The study will also check if the medicine is safe and if people can handle it well.

Inclusion: You can join if you have a stable body weight and a BMI over 25 (or 23 for Asian people). You must not have type 2 diabetes, or if you do, it should be controlled.

Exclusion: You cannot join if you have other liver diseases, history of pancreatitis, type 1 diabetes, or some serious health problems. You also cannot join if you had weight-loss surgery in the last 5 years or have issues with MRI scans.

  • Study lasts 28 weeks.
  • Participants will get medicine every week or every two weeks.
  • Safety and liver fat levels will be monitored.
Study details
    Metabolic Dysfunction-Associated Steatotic Liver Disease
    Non-alcoholic Fatty Liver Disease
    Nonalcoholic Fatty Liver Disease
    Liver Disease

NCT06482112

Merck Sharp & Dohme LLC

10 October 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.